Claude Nicaise's Insider Trades & SAST Disclosures
Claude Nicaise's most recent trade in Sarepta Therapeutics Inc was a trade of 9,746 Stock Options (right to buy) done . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Claude Nicaise.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 9,746 | 0 | - | - | Stock Options (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.18 per share. | 12 Mar 2025 | 9,746 | 30,303 (0%) | 0% | 25.2 | 245,404 | Common Stock |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Sale of securities on an exchange or to another person at price $ 99.64 per share. | 12 Mar 2025 | 2,491 | 27,812 (0%) | 0% | 99.6 | 248,203 | Common Stock |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,792 | 20,557 | - | - | Stock Options (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 2,383 | 20,557 (0%) | 0% | - | Common Stock | |
| Gain Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Cassava Sciences Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,679 | 3,679 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,846 | 18,174 (0%) | 0% | 0 | Common Stock | |
| Gain Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 3,257 | 3,257 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 1,523 | 16,328 (0%) | 0% | 0 | Common Stock | |
| Gain Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 5,077 | 5,077 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 2,953 | 14,805 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 5,518 | 5,518 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Claude Nicaise | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 2,726 | 11,852 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges